TB vaccines in clinical development

TB vaccines in clinical development

Show other versions (2)

The 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 - 24 April 2015, brought together a wide and diverse community involved in tuberculosis vaccine research and development to discuss the current status of, and future directions for this critical effort. This paper summarizes t...

Full description

Bibliographic Details
Main Authors:	Ginsberg, A, Ruhwald, M, Mearns, H, Mcshane, H
Format:	Journal article
Published:	Elsevier 2016

Similar Items

TB vaccines in clinical development
by: Ginsberg, AM, et al.
Published: (2016)

TB vaccines in clinical development
by: Ginsburg, A, et al.
Published: (2016)

TB vaccine development: where are we and why is it so difficult?
by: Wilkie, M, et al.
Published: (2014)

A review of clinical models for the evaluation of human TB vaccines.
by: O'Shea, M, et al.
Published: (2016)

Progress and challenges in TB vaccine development
by: Voss, G, et al.
Published: (2018)

Towards new TB vaccines
by: Brazier, B, et al.
Published: (2020)

Need for more TB vaccine field sites.
by: Mcshane, H
Published: (2009)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
by: Mcshane, H
Published: (2008)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
by: Minassian, A, et al.
Published: (2011)

New TB vaccine granted orphan drug status.
by: Lang, T, et al.
Published: (2005)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
by: Pepponi, I, et al.
Published: (2017)

Co-infection with HIV and TB: double trouble.
by: Mcshane, H
Published: (2005)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data.
by: McShane, H, et al.
Published: (2014)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
by: McShane, H, et al.
Published: (2014)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
by: Thomas, Z, et al.
Published: (2014)

Identification and evaluation of novel protective antigens for the development of a candidate TB subunit vaccine
by: Stylianou, E, et al.
Published: (2018)

Phase I/II clinical trial of MVA85A in individuals with latent tuberculosis: The first subunit TB vaccine in clinical trial
by: Sander, C, et al.
Published: (2005)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
by: Pathan, A, et al.
Published: (2012)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
by: Odutola, A, et al.
Published: (2012)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
by: Odutola, A, et al.
Published: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
by: Pathan, A, et al.
Published: (2012)

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents
by: Rustomjee, R, et al.
Published: (2013)

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents.
by: Rustomjee, R, et al.
Published: (2013)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
by: Tameris, M, et al.
Published: (2014)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
by: Tameris, M, et al.
Published: (2014)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
by: Whelan, K, et al.
Published: (2009)

Clinical Development of New TB Vaccines: Recent Advances and Next Steps
by: Mark Hatherill, et al.
Published: (2020-01-01)

Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
by: Owiafe, P, et al.
Published: (2012)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
by: Pinpathomrat, N, et al.
Published: (2021)

Tuberculosis vaccines in clinical trials.
by: Rowland, R, et al.
Published: (2011)

Developing an improved vaccine against tuberculosis.
by: Mcshane, H
Published: (2004)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
by: Harris, S, et al.
Published: (2011)

Insights and challenges in tuberculosis vaccine development
by: McShane, H
Published: (2019)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
by: Meyer, J, et al.
Published: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
by: Meyer, J, et al.
Published: (2013)

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults
by: Riste, M, et al.
Published: (2021)

Clinical testing of tuberculosis vaccine candidates
by: Hatherill, M, et al.
Published: (2016)

Update on TB Vaccine Pipeline
by: Carlos Martin, et al.
Published: (2020-04-01)

UNITE4TB: a new consortium for clinical drug and regimen development for TB
by: Boeree, MJ, et al.
Published: (2021)

Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.
by: Sander, C, et al.
Published: (2007)